SynthesisPloS one2019

CRISPR-cas gene-editing as plausible treatment of neuromuscular and nucleotide-repeat-expansion diseases: A systematic review.

Haris Babačić et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.